NasdaqGS:TECHLife Sciences
Will Bio-Techne's (TECH) Maintained Dividend Reshape Perceptions of Its Profit Outlook and Stability?
Bio-Techne Corporation reported fourth quarter earnings for the period ended June 30, 2025, with sales rising to US$316.96 million while posting a net loss of US$17.68 million, contrasting a net income of US$40.59 million a year earlier; the Board of Directors also affirmed a quarterly dividend of US$0.08 per share, payable on August 29, 2025.
The company’s move to maintain its dividend despite reporting a quarterly net loss signals a continued commitment to shareholder returns during a...